Paroxetine, Panorama and user reporting of ADRs: Consumer intelligence matters in clinical practice and post‐marketing drug surveillance
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We systematically analysed two complementary samples of emails relating to patients' problems with the popular SSRI antidepressant, paroxetine. These mainly concerned serious mood disorders and drug withdrawal symptoms. 1,374 emails were immediate responses to a major BBC‐TV documentary programme. These were contrasted with 862 messages on similar themes sent to a website discussion forum over a period of nearly three years. Despite the limitations of most individual email reports, we judged their collective weight to be profound. We also suggest that the value of “immersion” in a large body of such data may be greater than continuing exposure to a variable trickle of reports. We discuss the significance of these data in relation to the patient–prescriber relationship and pharmacovigilance. We suggest that the Internet offers unparalleled opportunities for soliciting and monitoring patients' reports of adverse drug reactions, and propose practical initiatives to capture peoples' experiences and thereby promote safer and more effective drug use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171 · cited 1×
“” and that withdrawal symptoms are “relatively mild and do not have features of a physical drug dependency syndrome” [11].”
BackgroundThe Antidepressant Web: Marketing depression and making medicines work
Medawar, C. (1997) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-1997-10203 · Cited by 92
Self-citation
Cited by
Systematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,245
Resisting medicines: a synthesis of qualitative studies of medicine taking
Pound, P., Britten, N., Morgan, M., Yardley, L., Pope, C., Daker-White, G., & Campbell, R. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2004.11.063 · Cited by 868
Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
Campbell, R., Pound, P., Morgan, M., Daker-White, G., Britten, N., Pill, R., Yardley, L., Pope, C., & Donovan, J. (2011) · Health Technology Assessment · doi:10.3310/hta15430 · Cited by 619
Blenkinsopp, A., Wilkie, P., Wang, M., & Routledge, P. A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02746.x · Cited by 302
Healy, D. (2006) · Global Pharmaceuticals · doi:10.1215/9780822387916-003 · Cited by 35
False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs
Hengartner, M. P., & Plöderl, M. (2018) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.20.1.6 · Cited by 10
Metadata
- Authors
- Medawar, C., Herxheimer, A., Bell, A., & Jofre, S.
- Venue
- International Journal of Risk & Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 2002-08
- Volume
- 15
- Issue
- 3-4
- Pages
- 161-169
- ISSN
- 0924-6479 (ISSN-L)
- 1878-6847
- OpenAlex
- W1467903879
- Cited by
- 89
- References
- 3
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.